Circulating Tumor Cells As Lung Cancer Biomarkers

Overview

Journal J Thorac Dis

Publisher AME Publishing Company

Specialty Pulmonary Medicine

Date 2012 Dec 4

PMID 23205290

Citations 8

Authors

Maria P Wong

Affiliations

Soon will be listed here.

Citing Articles

The Implication of Liquid Biopsy in the Non-small Cell Lung Cancer: Potential and Expectation.

Ren J, Liu R Methods Mol Biol. 2023; 2695:145-163.

PMID: 37450117 DOI: 10.1007/978-1-0716-3346-5_10.

Advances in lung cancer screening and early detection.

Li C, Wang H, Jiang Y, Fu W, Liu X, Zhong R Cancer Biol Med. 2022; .

PMID: 35535966 PMC: 9196057. DOI: 10.20892/j.issn.2095-3941.2021.0690.

[Progress of Liquid Biopsy in Early Diagnosis of Lung Cancer].

Song Z, Liu Y Zhongguo Fei Ai Za Zhi. 2018; 21(8):620-627.

PMID: 30172270 PMC: 6105353. DOI: 10.3779/j.issn.1009-3419.2018.08.08.

Blood-based tumor biomarkers in lung cancer for detection and treatment.

Mamdani H, Ahmed S, Armstrong S, Mok T, Jalal S Transl Lung Cancer Res. 2017; 6(6):648-660.

PMID: 29218268 PMC: 5709129. DOI: 10.21037/tlcr.2017.09.03.

Molecular characterization and prognostic significance of circulating tumor cells in patients with non-small cell lung cancer.

Tartarone A, Lerose R, Rodriquenz M, Mambella G, Calderoni G, Bozza G J Thorac Dis. 2017; 9(Suppl 13):S1359-S1363.

PMID: 29184674 PMC: 5676102. DOI: 10.21037/jtd.2017.07.80.

References

Tanaka F, Yoneda K, Kondo N, Hashimoto M, Takuwa T, Matsumoto S . Circulating tumor cell as a diagnostic marker in primary lung cancer. Clin Cancer Res. 2009; 15(22):6980-6. DOI: 10.1158/1078-0432.CCR-09-1095. View

Han K, Cao W, Che J, Bo S, Guo X, Huang G . First line chemotherapy with weekly docetaxel and cisplatin in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study. J Thorac Oncol. 2009; 4(4):512-7. DOI: 10.1097/jto.0b013e3181991d38. View

Punnoose E, Atwal S, Liu W, Raja R, Fine B, Hughes B . Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib. Clin Cancer Res. 2012; 18(8):2391-401. DOI: 10.1158/1078-0432.CCR-11-3148. View

Krebs M, Hou J, Sloane R, Lancashire L, Priest L, Nonaka D . Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J Thorac Oncol. 2011; 7(2):306-15. DOI: 10.1097/JTO.0b013e31823c5c16. View

Tan S, Lakshmi R, Chen P, Lim W, Yobas L, Lim C . Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients. Biosens Bioelectron. 2010; 26(4):1701-5. DOI: 10.1016/j.bios.2010.07.054. View

Krebs M, Sloane R, Priest L, Lancashire L, Hou J, Greystoke A . Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol. 2011; 29(12):1556-63. DOI: 10.1200/JCO.2010.28.7045. View

Ilie M, Long E, Butori C, Hofman V, Coelle C, Mauro V . ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma. Ann Oncol. 2012; 23(11):2907-2913. DOI: 10.1093/annonc/mds137. View

Pantel K, Deneve E, Nocca D, Coffy A, Vendrell J, Maudelonde T . Circulating epithelial cells in patients with benign colon diseases. Clin Chem. 2011; 58(5):936-40. DOI: 10.1373/clinchem.2011.175570. View

Hofman V, Long E, Ilie M, Bonnetaud C, Vignaud J, Flejou J . Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method. Cytopathology. 2011; 23(1):30-8. DOI: 10.1111/j.1365-2303.2010.00835.x. View

10.

Allard W, Matera J, Miller M, Repollet M, Connelly M, Rao C . Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004; 10(20):6897-904. DOI: 10.1158/1078-0432.CCR-04-0378. View

11.

Hofman V, Ilie M, Long E, Selva E, Bonnetaud C, Molina T . Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method. Int J Cancer. 2010; 129(7):1651-60. DOI: 10.1002/ijc.25819. View

12.

Nagrath S, Sequist L, Maheswaran S, Bell D, Irimia D, Ulkus L . Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature. 2007; 450(7173):1235-9. PMC: 3090667. DOI: 10.1038/nature06385. View

13.

Yasaka T, Mantich N, Boxer L, Baehner R . Functions of human monocyte and lymphocyte subsets obtained by countercurrent centrifugal elutriation: differing functional capacities of human monocyte subsets. J Immunol. 1981; 127(4):1515-8. View

14.

Hofman V, Ilie M, Bonnetaud C, Selva E, Long E, Molina T . Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls. Am J Clin Pathol. 2010; 135(1):146-56. DOI: 10.1309/AJCP9X8OZBEIQVVI. View

15.

Hou J, Krebs M, Lancashire L, Sloane R, Backen A, Swain R . Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol. 2012; 30(5):525-32. DOI: 10.1200/JCO.2010.33.3716. View

16.

Maheswaran S, Sequist L, Nagrath S, Ulkus L, Brannigan B, Collura C . Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med. 2008; 359(4):366-77. PMC: 3551471. DOI: 10.1056/NEJMoa0800668. View